"Gels" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
Descriptor ID |
D005782
|
MeSH Number(s) |
D20.280.320 D26.255.165.320
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gels".
Below are MeSH descriptors whose meaning is more specific than "Gels".
This graph shows the total number of publications written about "Gels" by people in this website by year, and whether "Gels" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gels" by people in Profiles.
-
Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2018 05 01; 178(5):681-690.
-
Surface deposition and phase behavior of oppositely charged polyion/surfactant ion complexes. 1. Cationic guar versus cationic hydroxyethylcellulose in mixtures with anionic surfactants. ACS Appl Mater Interfaces. 2009 Nov; 1(11):2431-42.
-
A simple method for DNA isolation from clotted blood extricated rapidly from serum separator tubes. Clin Chem. 2007 Mar; 53(3):522-4.
-
Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. Arch Dermatol. 2002 Mar; 138(3):325-32.
-
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. J Infect Dis. 1997 Oct; 176(4):892-8.